Variation of Neisseria gonorrhoeae protein II among isolates from an outbreak caused by a single gonococcal strain.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMC 262086)

Published in Infect Immun on July 01, 1985

Authors

R S Schwalbe, P F Sparling, J G Cannon

Articles citing this

Common themes in microbial pathogenicity. Microbiol Rev (1989) 7.78

Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci U S A (1988) 2.27

A 26-base-pair repetitive sequence specific for Neisseria gonorrhoeae and Neisseria meningitidis genomic DNA. J Bacteriol (1986) 1.88

In situ expression and localization of Neisseria gonorrhoeae opacity proteins in infected epithelial cells: apparent role of Opa proteins in cellular invasion. J Exp Med (1991) 1.81

Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med (1994) 1.80

Escherichia coli expressing a Neisseria gonorrhoeae opacity-associated outer membrane protein invade human cervical and endometrial epithelial cell lines. Proc Natl Acad Sci U S A (1992) 1.38

Antigenic and structural differences among six proteins II expressed by a single strain of Neisseria gonorrhoeae. Infect Immun (1987) 1.35

Interactions of Neisseria gonorrhoeae with human neutrophils. Clin Microbiol Rev (1989) 1.29

Genetic mechanisms and biological implications of phase variation in pathogenic neisseriae. Clin Microbiol Rev (1989) 1.11

Resistance of Neisseria gonorrhoeae to neutrophils. Front Microbiol (2011) 1.06

Characterization of a 78-kilodalton outer membrane protein of Haemophilus somnus. Infect Immun (1990) 0.99

Gonococci exit apically and basally from polarized epithelial cells and exhibit dynamic changes in type IV pili. Cell Microbiol (2006) 0.92

In vivo selection for Neisseria gonorrhoeae opacity protein expression in the absence of human carcinoembryonic antigen cell adhesion molecules. Infect Immun (2006) 0.91

Genetic transformation of genes for protein II in Neisseria gonorrhoeae. J Bacteriol (1986) 0.87

Neisseria gonorrhoeae: a versatile pathogen. J Clin Pathol (1987) 0.83

Construction and characterization of a derivative of Neisseria gonorrhoeae strain MS11 devoid of all opa genes. J Bacteriol (2012) 0.83

Characterisation of Neisseria gonorrhoeae in semen during urethral infection in men. Genitourin Med (1997) 0.79

Expression of Opacity Proteins Interferes with the Transmigration of Neisseria gonorrhoeae across Polarized Epithelial Cells. PLoS One (2015) 0.77

The roles of sexual and asexual gene transfer in emergence of antibiotic resistant gonococci. Trans Am Clin Climatol Assoc (1986) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol (1963) 45.03

Studies on gonococcus infection. XIV. Cell wall protein differences among color/opacity colony variants of Neisseria gonorrhoeae. Infect Immun (1978) 5.08

Variations in surface protein composition associated with virulence properties in opacity types of Neisseria gonorrhoeae. J Gen Microbiol (1979) 4.66

Colony opacity and protein II compositions of gonococci. Infect Immun (1982) 3.12

Effects of proteolytic enzymes on the outer membrane proteins of Neisseria gonorrhoeae. Infect Immun (1981) 2.82

Altered outer membrane protein in different colonial types of Neisseria gonorrhoeae. J Bacteriol (1977) 2.54

Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J Infect Dis (1984) 2.28

Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis. Infect Immun (1980) 2.11

Immunological characteristics of gonococcal outer membrane protein II assessed by immunoprecipitation, immunoblotting, and coagglutination. J Exp Med (1983) 1.92

Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect Immun (1984) 1.83

Rates in vitro changes of gonococcal colony opacity phenotypes. Infect Immun (1982) 1.79

Relation of protein I and colony opacity to serum killing of Neisseria gonorrhoeae. J Infect Dis (1982) 1.50

The differential susceptibility of gonococcal opacity variants to sex hormones. Can J Microbiol (1982) 1.07

Articles by these authors

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91

Genetic transformation of Neisseria gonorrhoeae to streptomycin resistance. J Bacteriol (1966) 8.51

Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82

Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae. J Infect Dis (1973) 5.17

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med (1989) 5.02

Inheritance of low-level resistance to penicillin, tetracycline, and chloramphenicol in Neisseria gonorrhoeae. J Bacteriol (1975) 5.02

Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect Immun (1981) 4.28

Genetic mapping of linked antibiotic resistance loci in Neisseria gonorrhoeae. J Bacteriol (1974) 4.13

Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med (1995) 3.77

Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae. J Bacteriol (1978) 3.71

Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol (1987) 3.61

Diagnosis and treatment of syphilis. N Engl J Med (1971) 3.28

Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin. Infect Immun (1982) 3.27

Colonial morphology of Neisseria gonorrhoeae isolated from males and females. J Bacteriol (1967) 3.22

Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors. J Bacteriol (1992) 3.21

The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae. J Bacteriol (1995) 3.10

DNA transformation leads to pilin antigenic variation in Neisseria gonorrhoeae. Nature (1988) 2.98

Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production. Infect Immun (1985) 2.94

Antibiotic resistance in Neisseria gonorrhoeae. Med Clin North Am (1972) 2.89

A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med (1985) 2.85

Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species. Infect Immun (1984) 2.65

Species-specific uptake of DNA by gonococci is mediated by a 10-base-pair sequence. J Bacteriol (1991) 2.64

The genetics of the gonococcus. Annu Rev Microbiol (1984) 2.63

Kasugamycin resistance: 30S ribosomal mutation with an unusual location on the Escherichia coli chromosome. Science (1970) 2.57

Altered outer membrane protein in different colonial types of Neisseria gonorrhoeae. J Bacteriol (1977) 2.54

Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol (1994) 2.53

Factors affecting genetic transformation of Neisseria gonorrhoeae. J Bacteriol (1977) 2.45

Loss of low-level antibiotic resistance in Neisseria gonorrhoeae due to env mutations. J Bacteriol (1975) 2.43

Phase variation of gonococcal protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell (1989) 2.42

Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41

Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1999) 2.41

Molecular cloning and characterization of the structural gene for protein I, the major outer membrane protein of Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1987) 2.40

The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol Microbiol (1998) 2.33

Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J Bacteriol (1994) 2.32

Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci U S A (1988) 2.27

Recombination among protein II genes of Neisseria gonorrhoeae generates new coding sequences and increases structural variability in the protein II family. Mol Microbiol (1988) 2.26

Growth inhibition among strains of Neisseria gonorrhoeae due to production of inhibitory free fatty acids and lysophosphatidylethanolamine: absence of bacteriocins. Infect Immun (1974) 2.25

Single doses of methacycline and doxycycline for gonorrhea: a cooperative study of the frequency and cause of treatment failure. J Infect Dis (1973) 2.23

Conjugal transfer of the gonococcal penicillinase plasmid. Science (1977) 2.22

Conjugative plasmids in Neisseria gonorrhoeae. J Bacteriol (1978) 2.19

Multiple biological activities of human recombinant interleukin 1. J Clin Invest (1986) 2.16

Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12

Spectinomycin sulfate and aqueous procaine penicillin G in treatment of female gonorrhea. Antimicrob Agents Chemother (Bethesda) (1965) 2.11

Penicillin sensitivity and serum resistance are independent attributes of strains of Neisseria gonorrhoeae causing disseminated gonococcal infection. Infect Immun (1977) 2.09

Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen. Infect Immun (1981) 2.09

Effects of serum carrier proteins on the growth of pathogenic neisseriae with heme-bound iron. Infect Immun (1987) 2.05

Altered crystal violet permeability and lytic behavior in antibiotic-resistant and -sensitive mutants of Neisseria gonorrhoeae. J Bacteriol (1975) 2.04

Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae. Infect Immun (1988) 2.02

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01

Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae. J Bacteriol (1974) 1.96

Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94

Haemophilus influenzae can use human transferrin as a sole source for required iron. Infect Immun (1985) 1.94

New concepts on the pathogenesis of fever. Rev Infect Dis (1988) 1.94

Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest (1994) 1.93

Ribosomes from Escherichia coli merodiplods heterozygous for resistance to streptomycin and to spectinomycin. J Mol Biol (1968) 1.92

Loss of transferrin receptor activity in Neisseria meningitidis correlates with inability to use transferrin as an iron source. Infect Immun (1988) 1.91

Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. J Infect Dis (1986) 1.90

Genetics of resistance in a non-beta-lactamase-producing gonococcus with relatively high-level penicillin resistance. Antimicrob Agents Chemother (1986) 1.90

Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J Infect Dis (1994) 1.88

Sequence-specific DNA uptake in transformation of Neisseria gonorrhoeae. J Bacteriol (1982) 1.86

Mutations to increased antibiotic sensitivity in naturally-occurring gonococci. Nature (1978) 1.83

Neisseria meningitidis produces iron-regulated proteins related to the RTX family of exoproteins. J Bacteriol (1993) 1.83

Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect Immun (1984) 1.83

Gonococcal infection: a model of molecular pathogenesis. N Engl J Med (1985) 1.82

Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med (1994) 1.80

Genetic locus (nmp-1) affecting the principal outer membrane protein of Neisseria gonorrhoeae. J Bacteriol (1980) 1.80

Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr (1990) 1.80

Transformation-derived Neisseria gonorrhoeae plasmids with altered structure and function. J Bacteriol (1979) 1.78

Two genetic loci for resistance to kasugamycin in Escherichia coli. J Bacteriol (1973) 1.75

In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol (1989) 1.73

Aerobactin utilization by Neisseria gonorrhoeae and cloning of a genomic DNA fragment that complements Escherichia coli fhuB mutations. J Bacteriol (1987) 1.72

Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol (1989) 1.72

Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol (1988) 1.70

Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin-binding proteins. J Bacteriol (1996) 1.70

Increased plasma interleukin-1 activity in women after ovulation. Science (1985) 1.70

Human immune response to iron-repressible outer membrane proteins of Neisseria meningitidis. Infect Immun (1986) 1.70

Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus. Infect Immun (1981) 1.67

Isolation by streptonigrin enrichment and characterization of a transferrin-specific iron uptake mutant of Neisseria meningitidis. Microb Pathog (1987) 1.66

Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol Microbiol (1992) 1.66

A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide. J Immunol Methods (1981) 1.65

Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes. J Bacteriol (1991) 1.65

Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide. J Infect Dis (1984) 1.64

Cloning, sequencing, and characterization of the gene encoding FrpB, a major iron-regulated, outer membrane protein of Neisseria gonorrhoeae. J Bacteriol (1995) 1.63

Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J Infect Dis (1999) 1.62

Identification and cloning of a fur homologue from Neisseria meningitidis. Mol Microbiol (1994) 1.60

Endogenous pyrogen activity in human plasma after exercise. Science (1983) 1.57

Metabolic changes following eccentric exercise in trained and untrained men. J Appl Physiol (1985) (1986) 1.56

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol (1988) 1.56

Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Immun (1995) 1.56

Genital chlamydial infections. Am J Epidemiol (1976) 1.56

Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am J Physiol (1993) 1.54

Standardization of nomenclature of body composition in weight loss. Am J Clin Nutr (1997) 1.54

Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet (1991) 1.53

Proposed changes for NIH's Center for Scientific Review. Panel on Scientific Boundaries for Review. Center for Scientific Review Advisory Committee, National Institutes of Health. Science (1999) 1.52